First Medtronic robot spine cases

Spine surgery robots are built to help place screws and tools in the right spot while a patient’s anatomy shifts on the operating table. This week, surgeons in Virginia and Kentucky said they performed the first live spine operations with Medtronic’s new Stealth AXiS Autopilot platform. (massdevice.com) Virginia Spine Institute in Reston said Christopher Good, Colin Haines and Ehsan Jazini used the Food and Drug Administration-cleared system on April 21, 2026. Norton Leatherman Spine in Louisville said Jeffrey Gum performed a separate first-in-world case with the same platform and had helped design it. (marketwatch.com, wlky.com) Medtronic says Stealth AXiS combines preoperative planning, live navigation and robotic guidance in one spine system. Its key feature, called LiveAlign, tracks each vertebra in real time so surgeons can see motion during the case without stopping for repeated imaging. (medtronic.com, prnewswire.com) That pitch targets a basic problem in spine surgery: bones can move after the first scan, and surgeons may need new images to confirm alignment before placing implants. Medtronic received Food and Drug Administration clearance for Stealth AXiS in February 2026 and said the system was built on its older StealthStation navigation and Mazor robotic platforms. (prnewswire.com, medtronic.com) Hospitals have heard similar promises before, and adoption has not kept rising in a straight line. Becker’s Spine, citing American Spine Registry 2026 data, reported last week that use of robotics and computer assistance in lumbar and cervical spine surgery has flattened since 2020. (beckersspine.com, aaos-annualmeeting-presskit.org) Surgeons interviewed by Becker’s said cost, training, operating-room workflow and market saturation still shape buying decisions. That leaves Medtronic needing more than first cases: hospitals usually want proof that a robot fits daily practice and improves outcomes enough to justify the capital expense. (beckersspine.com) The commercial stakes are large because spine robotics remains a crowded medtech category. Market researchers at Mordor Intelligence estimate the spine robotic surgery market at $533.74 million in 2026 and project it to reach $988.75 million by 2031, with Medtronic, Stryker and Globus Medical among the major companies. (mordorintelligence.com) Medtronic is also trying to make Stealth AXiS more useful inside the operating room through partnerships, including a GE HealthCare integration announced last week that adds intraoperative ultrasound imaging. The idea is to give surgeons another live view during a case, not just the robot’s plan and navigation screens. (massdevice.com) Investors, though, are not valuing the company on robot launches alone. UBS cut its Medtronic price target to $90 from $104 on April 22 while keeping a neutral rating, a sign that Wall Street still wants broader evidence on growth and execution. (marketbeat.com) The first live cases give Medtronic a new proof point, but the next test is less theatrical than a world-first claim. It is whether Stealth AXiS moves from a handful of showcase operating rooms into routine spine programs that measure time, revisions, complications and cost case by case. (massdevice.com, beckersspine.com)